Effect of topical application of finasteride in the treatment of hirsutism in women

Studying and preparig semi-solid formulations of Finastride and Clinical evaluation of optimal form in the treatment of Hirsutism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013072214106N1

Enrollment

Registered

2013-09-11

Start date

2013-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirsutism. Hirsutism

Interventions

Intervention 1: Interventional group: Finasteride, 0.25% topical gel, twice daily for six months. Intervention 2: Control group: placebo, placebo topical gel, twice daily for six months.

Treatment - Drugs

Placebo

Interventional group: Finasteride, 0.25% topical gel, twice daily for six months

Control group: placebo, placebo topical gel, twice daily for six months

Eligibility

Sex/Gender

Female

Age

18 Years to 48 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: women after puberty that have hirsutism based on Ferriman-Gallwey scoring system. Exclusion criteria: 1. The patient uses any other drugs. 2. History of other disease with an appearance like hirsutism. 3. The patient is will less to continue participating in this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of hirsutism. Timepoint: First day - 1 week later- every one month untill 6 months later. Method of measurement: Ferriman-Gullway score.	—

Secondary

Measure	Time frame
Acne. Timepoint: First day - 6 months later. Method of measurement: Based on physician's discription.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Masoud

Kermanshah University of Medical Sciences

saharmasoud@yahoo.com+98 83 1835 9646

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026